Energy drinks, stimulant products linked to cardiac arrest, heart attack in young adults
Caffeinated energy drinks and stimulant supplements appeared disproportionately more often in FDA reports of serious cardiovascular events, including cardiac arrest and heart attacks, especially among adults ages 18 to 34, according to new, independent, preliminary research presented at the American Heart Association's Scientific Sessions 2026, held Nov. 6–9 in Chicago.
New research presented at the American Heart Association's Scientific Sessions 2026 suggests a link between energy drinks and stimulant supplements, as well as other cardiovascular events among young adults, particularly those aged 18 to 34. According to a preliminary study, these products are frequently mentioned in FDA reports of serious cardiac issues, including cardiac arrest and heart attacks.
The popularity of caffeinated energy drinks has surged over the past decade, with sales surpassing $20 billion in 2024. While research on these products is limited, evidence indicates that high caffeine doses can lead to cardiovascular problems. Reports from healthcare professionals describe cases of arrhythmias or sudden cardiac death in young adults who have consumed these products, many of whom had no prior heart disease risks.
The 2026 American Heart Association scientific statement on caffeine and cardiovascular disease states that consuming up to 400 mg of caffeine daily is generally safe for most adults. However, some energy drinks contain up to three times more caffeine per fluid ounce than brewed coffee, and certain pre-workout supplements have more than 12 times the caffeine.
As energy drinks and stimulant supplements are regulated as foods or dietary supplements rather than medications, they do not undergo the same premarket safety testing. This raises concerns about the potential cardiovascular risks associated with these products, especially for regular consumers who may exceed recommended caffeine limits.
Researchers are calling for more systematic safety monitoring of caffeine- and stimulant-containing products and urge healthcare professionals to inquire about their younger patients' consumption habits.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
